Issue 12, 2022

An autophagy-inhibitory MOF nanoreactor for tumor-targeted synergistic therapy

Abstract

An autophagy-inhibitory metal–organic framework (MOF) nanoreactor was developed for tumor-targeted synergistic therapy. The nanoreactor could inhibit autophagy to enhance the glucose oxidase (GOx)-mediated starvation therapy. The H2O2 generated in this process induced the polarization of macrophages to the M1 phenotype, which further enhanced the therapeutic effect.

Graphical abstract: An autophagy-inhibitory MOF nanoreactor for tumor-targeted synergistic therapy

Supplementary files

Article information

Article type
Communication
Submitted
13 Apr 2022
Accepted
16 May 2022
First published
19 May 2022

Biomater. Sci., 2022,10, 3088-3091

An autophagy-inhibitory MOF nanoreactor for tumor-targeted synergistic therapy

X. Liu, P. Gao, M. Shi, Y. Chen, W. Pan, N. Li and B. Tang, Biomater. Sci., 2022, 10, 3088 DOI: 10.1039/D2BM00579D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements